SCHEMBL24088155

SCHEMBL24088155

COc1c(F)cc(CSc2nc(-c3cccs3)c(C#N)c(=O)[nH]2)cc1F

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRNP P04156 5/20 0.66
▸ RXFP1 Q9HBX9 5/20 0.66
▸ NPSR1 Q6W5P4 4/20 0.66
▸ MEN1 O00255 4/20 0.66
▸ KMT2A Q03164 4/20 0.66
▸ USP2 O75604 1/20 0.66
▸ POLB P06746 1/20 0.66
▸ PKM P14618 1/20 0.66
▸ BLM P54132 1/20 0.66
▸ SAE1 Q9UBE0 1/20 0.66
▸ UBA2 Q9UBT2 1/20 0.66
▸ L3MBTL1 Q9Y468 1/20 0.66
▸ ACMSD Q8TDX5 7/20 0.63
▸ MAPT P10636 2/20 0.59
▸ KDM4E B2RXH2 2/20 0.59
▸ ALDH1A1 P00352 1/20 0.59
▸ CYP2C19 P33261 2/20 0.58
▸ BRD4 O60885 6/20 0.56
▸ PSMD14 O00487 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24088168 0.91 ACMSD (0.66) PRNPRXFP1NPSR1MEN1KMT2A
SCHEMBL26847260 0.90 PRNP (0.69) PRNPRXFP1NPSR1MEN1KMT2A
SCHEMBL23853857 0.88 PRNP (0.69) PRNPRXFP1NPSR1MEN1KMT2A
SCHEMBL17548438 0.81 ACMSD (0.78) PRNPRXFP1NPSR1MEN1KMT2A
SCHEMBL26847151 0.81 ACMSD (0.69) PRNPRXFP1NPSR1MEN1KMT2A
SCHEMBL23849818 0.80 ACMSD (0.76) PRNPRXFP1NPSR1MEN1KMT2A
SCHEMBL31053424 0.80 ACMSD (0.76) PRNPRXFP1NPSR1MEN1KMT2A
SCHEMBL31053406 0.79 ACMSD (0.78) PRNPRXFP1NPSR1MEN1KMT2A
SCHEMBL23850223 0.79 ACMSD (0.78) PRNPRXFP1NPSR1MEN1KMT2A
SCHEMBL23892711 0.79 PRNP (0.76) PRNPRXFP1NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024240882-A1 HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR USE IN TREATING ACUTE INFLAMMATION TES PHARMA S.R.L. (IT) 2024-11-28 — — WO disclosed
CN-118496217-A Inhibitors of alpha-amino-beta-carboxyhexadienoic acid semialdehyde decarboxylase TES制药有限责任公司 2024-08-16 — — CN disclosed
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 PRNP 569/4885RXFP1 4311/4885NPSR1 2669/4885
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 PRNP 569/4885RXFP1 4311/4885NPSR1 2669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback